Abhishek K. Srivastava - Aug 12, 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Vice President, Techncial Operations
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Stock symbol
TCRT
Transactions as of
Aug 12, 2022
Transactions value $
$0
Form type
4
Date filed
8/16/2022, 05:00 PM
Previous filing
Aug 15, 2022
Next filing
Sep 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +250K $0.00 250K Aug 12, 2022 Common Stock 250K $1.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares underlying the options vest on August 3, 2023, and with respect to the remainder, in twelve successive equal quarterly installments measured from August 3, 2023, subject to the Reporting Person's continued service through each such date.

Remarks:

Vice President, Techncial Operations